Capital rises to EGP 733.9 million. Five analysts rate Cleopatra Hospital stock Outperform

Published on 10/14/2026 at 00:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached EGP 4.31 billion in the first half of 2026 versus EGP 3.38 billion. Five analysts rate Cleopatra Hospital stock Outperform.

Capital and earnings update

Cleopatra Hospital's capital increased to EGP 733.9 million on September 16, 2026.
First-half 2026 revenue reached EGP 4.31 billion, while net income totaled EGP 342.0 million.
Five analysts give the company an Outperform consensus with an average target of EGP 17.48.

CLHO, EGS729J1C018, Illustration mit AI erstellt.

Cleopatra Hospital raised issued and paid-in capital to EGP 733.9 million on September 16, 2026, while five analysts gave Cleopatra Hospital stock an Outperform consensus. Banker News reported that the increase amounted to EGP 9.18 million, while MarketScreener listed five analysts and an average target of EGP 17.48.

First-half results set the baseline

For the six months ended June 30, 2026, revenue reached EGP 4.31 billion, compared with EGP 3.38 billion in the comparable period. Net income totaled EGP 342.0 million, down from EGP 521.5 million, according to Banker News.

The figures show a clear split between operating growth and bottom-line performance. Revenue increased by EGP 930.0 million, while net income decreased by EGP 179.5 million, making profitability the central counterweight to the expansion story.

Capital increase adds 18.36 million shares

On September 16, 2026, the ordinary general meeting approved 18.36 million new shares with a nominal value of EGP 0.50 each. The increase was funded from retained earnings and supported employee incentive plan tranches for 2023, 2024 and 2026, Banker News reported.

The total share count rose to 1.467 billion after the transaction, while issued and paid-in capital moved from EGP 724.7 million to EGP 733.9 million. The structure therefore adds shares without requiring a cash contribution from existing shareholders.

What does the raise change?

The September 3, 2026 board meeting minutes added a separate operating development, as the company signed an agreement for construction of the Sharm El-Sheikh to Taba submarine cable, according to Metro Brokerage. Together with the 1.467 billion-share count, the disclosure places capital structure and expansion activity alongside the first-half earnings comparison.

Egypt listing and investor context

Cleopatra Hospital is listed on the Egyptian Exchange under CLHO.CA and operates in the healthcare sector. MarketScreener identifies five analysts in its consensus, with an Outperform average view and an EGP 17.48 average target, providing a quantified market reference for the company after the capital increase.